Drug application
KITPROZY (CARFILZOMIB)
Drugs@FDA NDA 220712 · AMNEAL PHARMS NY
Key facts
| Drug name | KITPROZY |
|---|---|
| Active ingredients | CARFILZOMIB |
| Application type | NDA |
| Application number | 220712 |
| Company | AMNEAL PHARMS NY |
| Dosage forms | VIAL, SINGLE-USE |
| Strength | 60MG/ML, 2/ML |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Mar 19, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: